References
- G. J. Kahaly, S. K. Grebe, M. A. Lupo, N. McDonald and J. A. Sipos, Graves' disease; diagnostic and therapeutic challenges (multimedia activity), Am. J. Med. 124 (2011) 2-3; DOI: 10.1016/j.amjmed.2011.03.001.
- L. H. Duntas, Thyroid disease and lipids, Thyroid 12 (2002) 287-293; DOI: 10.1089/10507250252949405287.
- U. Subudhi and G. B. Chainy, Expression of hepatic antioxidant genes in l-thyroxine-induced hyperthyroid rats: regulation by vitamin E and curcumin, Chem. Biol. Interact. 183 (2010) 304-316; DOI: 10.1016/j.cbi.2009.11.004.
- Lj. Mayer, Z. Romic, F. Skreb, V. Bacic Vrca, I. Cepelak, T. Zanic-Grubisic and M. Kirin, Antioxidants in patients with hyperthyroidism, Clin. Chem. Lab. Med. 42 (2004) 154-158; DOI: 10.1515/CCLM.2004.028.
- A. Seven, O. Seymen, S. Hatemi, H. Hatemi, G. Yiğit and G. Candan, Antioxidant status in experimental hyperthyroidism: effect of vitamin E supplementation, Clin. Chim. Acta 256 (1996) 65-74; DOI: 10.1016/S0009-8981(96)06415-7.
- A. Seven, E. Taşan, F. Inci, H. Hatemi and G. Burçak, Biochemical evaluation of oxidative stress in propylthiouracil treated hyperthyroid patients. Effects of vitamin C supplementation, Clin. Chem. Lab. Med. 6 (1998) 767-770; DOI: 10.1515/CCLM.1998.136.
- V. B. Vrca, F. Skreb, I. Cepelak, Z. Romic and Lj. Mayer, Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium, Clin. Chim. Acta 341 (2004) 55-63; DOI: 10.1016/j.cccn.2003.10.028.
- M. Shargorodsky, O. Debby, Z. Matas and R. Zimlichman, Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors, Nutr. Metab. 7 (2010) 55; DOI: 10.1186/1743-7075-7-55.
- H. Abdollahzad, S. Eghtesadi, I. Nourmohammadi, M. Khadem-Ansari, H. Nejad-Gashti and A. Esmaillzadeh, Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients, Int. J. Vitam. Nutr. Res. 79 (2009) 281-287; DOI: 10.1024/0300-9831.79.56.281.
- F. Deyhim, C. Gonzales, C. Garcia, A. Villarreal, K. Garcia, R. Rios, K. Mandadti and B. S. Patil, Vitamin E does not modulate plasma lipid profile or C-reactive protein despite suppressing oxidative stress in orchiectomized rats, J. Med. Food 10 (2007) 559-562; DOI: 10.1089/jmf.2006.245.
- E. A. Lucas, T. Y. Chen, S. C. Chai, L. Devareddy, S. Juma, C. I. Wei, Y. B. Tripathi, B. P. Daggy, D. F. Hwang and B. H. Arjmandi, Effect of vitamin E on lipid parameters in ovariectomized rats, J. Med. Food 9 (2006) 77-83; DOI: 10.1089/jmf.2006.9.77.
- L. Thomas, Thyroid Function, in Clinical Laboratory Diagnostics, 1st ed., TH-Books Verlagsgesellschaft mbH, Frankfurt/Main 1998, pp. 1004-1023.
- G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. M. Cats, K. Orth-Gomér, J. Perk, K. Pyörälä, J. L. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen and D. Wood, European guidelines on cardiovascular disease and prevention in clinical practice, Atherosclerosis 171 (2003) 145-55; DOI: 10.1016/j.atherosclerosis.2003.10.001.
- M. J. Diekman, N. Anghelescu, E. Endert, O. Bakker and W. M. Wiersinga, Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes, J. Clin. Endocrinol Metab. 85 (2000) 1857-1862; DOI: 10.1210/jc.85.5.1857.
- E. Brzezinska-Slebodinzska, Fever induced oxidative stress: the effect on thyroid status at the 5'-monodeionidase activity, protective role of selenium and vitamin E, J. Physiol. Pharmacol. 52 (2001) 275-284.